Correlation Between Vaccibody and Ikena Oncology

Can any of the company-specific risk be diversified away by investing in both Vaccibody and Ikena Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaccibody and Ikena Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vaccibody As and Ikena Oncology, you can compare the effects of market volatilities on Vaccibody and Ikena Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaccibody with a short position of Ikena Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaccibody and Ikena Oncology.

Diversification Opportunities for Vaccibody and Ikena Oncology

0.0

Correlation Coefficient

Vaccibody  Ikena Oncology

Pay attention - limited upside

The 3 months correlation between Vaccibody and Ikena is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Vaccibody As and Ikena Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ikena Oncology and Vaccibody is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaccibody As are associated (or correlated) with Ikena Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ikena Oncology has no effect on the direction of Vaccibody i.e., Vaccibody and Ikena Oncology go up and down completely randomly.

Pair Corralation between Vaccibody and Ikena Oncology

If you would invest (100.00) in Vaccibody As on December 1, 2024 and sell it today you would earn a total of  100.00  from holding Vaccibody As or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Vaccibody As  vs.  Ikena Oncology

Vaccibody As

Risk-Adjusted Performance

Very Weak

Over the last 90 days Vaccibody As has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental indicators, Vaccibody is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

Ikena Oncology

Risk-Adjusted Performance

Very Weak

Over the last 90 days Ikena Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Vaccibody and Ikena Oncology

The main advantage of trading using opposite Vaccibody and Ikena Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaccibody position performs unexpectedly, Ikena Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ikena Oncology will offset losses from the drop in Ikena Oncology's long position.

The idea behind Vaccibody As and Ikena Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.